Ardent Health (NYSE:ARDT) Releases Earnings Results, Beats Estimates By $0.08 EPS

Ardent Health (NYSE:ARDT) issued its earnings results on Wednesday. The company reported $0.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.23 by $0.08, FiscalAI reports. Ardent Health had a return on equity of 10.35% and a net margin of 1.22%. The company had revenue of $1.62 billion for the quarter, compared to analysts’ expectations of $1.60 billion.

Ardent Health Stock Up 10.7%

Shares of Ardent Health stock traded up $1.26 on Wednesday, hitting $12.97. The company had a trading volume of 1,076,331 shares, compared to its average volume of 454,994. The stock has a market capitalization of $1.83 billion, a price-to-earnings ratio of 23.57, a P/E/G ratio of 3.32 and a beta of 0.58. Ardent Health has a 1 year low of $7.71 and a 1 year high of $14.82. The stock has a 50 day moving average of $11.22 and a 200-day moving average of $10.02. The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.99 and a current ratio of 2.10.

Wall Street Analysts Forecast Growth

A number of analysts have commented on the stock. The Goldman Sachs Group restated a “neutral” rating and set a $13.00 price target on shares of Ardent Health in a research note on Thursday, August 6th. Truist Financial raised their price objective on shares of Ardent Health from $12.00 to $13.00 and gave the company a “buy” rating in a research note on Thursday, August 6th. Zacks Research raised shares of Ardent Health from a “strong sell” rating to a “hold” rating in a research note on Monday, September 7th. Wall Street Zen cut shares of Ardent Health from a “buy” rating to a “hold” rating in a report on Sunday, July 12th. Finally, Guggenheim lifted their price objective on shares of Ardent Health from $13.00 to $14.00 and gave the company a “buy” rating in a report on Thursday, August 6th. Seven investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, Ardent Health has a consensus rating of “Hold” and a consensus price target of $12.79.

Ardent Health Company Profile

Ardent Health is a U.S. healthcare services company that operates hospitals, outpatient facilities and physician practices. Its services include emergency and acute care, surgery, cardiology, orthopedics, oncology, women’s health, behavioral health, rehabilitation, imaging and other specialty and primary care offerings.

The company serves patients through regional health networks and hospital campuses primarily in Texas, Oklahoma, New Mexico and other U.S. markets. In addition to hospital-based care, Ardent operates outpatient clinics, urgent care locations and other facilities designed to provide services across different stages of the patient-care process.

Ardent Health was founded in 2001 and became a publicly traded company on the New York Stock Exchange in 2024.